skip to main content
Experience List
DWT
  • Email Page
  • Create PDF
  • Print Page

Joseph P. Whitford

WhitfordJoseph
Partner
T206.757.8167
F206.757.7167
Joe Whitford focuses his corporate finance practice in startups and the emerging-company sector, where he has served for more than 30 years as general counsel and advisor to high-growth software, Internet, health care, medical device, biotech, wireless and specialty retail business ventures. He has guided management, boards of directors and investors through founder formation matters, equity compensation planning, angel and venture capital investments, strategic partnerships, license arrangements, mergers and acquisitions, and public offerings.

Prior to private practice, Joe was an attorney with the Division of Corporation Finance at the Securities and Exchange Commission in Washington, D.C. He is a frequent speaker at business and legal seminars.

Representative Experience

Investment for Crestline Management LP

Represented Crestline Management LP in follow on $56,000,000 Series A Preferred Stock financing of Juno Therapeutics, Inc., a cancer drug developer. (2014)

Securities transaction for CareCap LLC

Series A-2 Preferred Unit financing for CareCap LLC, a healthcare financial technology software developer. (2014)

Securities transaction for instaCOVER LLC

Series A-2 Preferred Unit financing for instaCOVER LLC, a financial technology software developer. (2014)

Investment for Alaska Permanent Fund Corporation

Represented Alaska Permanent Fund Corporation in $120,000,000 Series A Preferred Stock financing of Juno Therapeutics Inc., a cancer drug developer. (2013)

Investment for Ignition Growth Management

Represented Ignition Growth Management in $22 million Series B Preferred Stock financing of PaxVax. (2013)

Investment for Ignition Growth Management

Represented Ignition Growth Management in debt financing of PaxVax, a pharmaceutical therapeutic drug developer. (2013)

NanoFacture Inc.

Technology spinout from University of Washington. (2013)

Securities transaction for Cadence Biomedical

Series A-2 Preferred Stock financing for Cadence Biomedical, a medical equipment device manufacturer. (2013)

Securities transaction for Medical Search Technologies

Series A-2 Preferred Stock financing for Medical Search Technologies, a medical web-based software developer. (2013)

University spinout

Represented NanoFacture Inc. in technology spinout from the University of Washington. (2013)

University spinout

Represented Oricula Therapeutics in technology spinout from the University of Washington. (2013)

Sale of business for Blueview Technologies Inc.

Represented software developer in sale to Teledyne Technologies. (2012)

Sale of business for Cardiovascular Decision Technologies, Inc.

Represented medical device software developer in its sale to a national health care conglomerate. (2011)

Sale of business for Geospiza, Inc.

Represented Geospiza Inc., a bioinformatics company, in its merger with PerkinElmer. (2011)

Securities transaction for Julep Nail Parlor Company

Series C Preferred Stock angel financing for retail service company. (2011)

Securities transaction for Previser Corporation

Represented Previser in a follow on round of investment from Ignition Partners and other investors. (2011)

Industry joint venture for Cardiovascular Decisions

Represented a medical device company in a strategic product and technology development license of its cardiac medical device software to a major corporate partner. (2010)

Industry joint venture for Previser Corporation

Represented developer of an oral disease analysis software product to the dental sector in a strategic distribution agreement with a major retail health care conglomerate. (2010)

Securities transaction for CourtTrax Corporation

Negotiation of follow on venture funding investment from Texas Pacific Group, Benchmark Capital, Foundation Capital, and MHS Capital. (2010)

Securities transaction for Geospiza Inc.

Represented Geospiza in a Series B Preferred Stock angel financing, and corporate governance matters. (2010)

Securities transaction for Julep Nail Parlor Company

Represented Julep in an angel financing round of Series B Preferred Stock. (2010)

Corporate finance for Cardiovascular Decisions

Represented a medical device software and service company which develops software to facilitate the interpretation of echocardiograms in its initial organization as well as a round on angel financing. (2009)

Sale of business for Confirma

Represented Confirma in its $22 million merger with Merge Healthcare Inc. Confirma is the creator of Cadstream, a medical device software system that automates the processing of breast magnetic resonance imaging studies. (2009)

Sale of business for Cytopeia, Inc

Represented a biotech equipment manufacturer in its sale to Becton Dickinson and Co. (2008)

Sale of business for Sonotech, Inc.

Representation of Sonotech, Inc., a medical products manufacturer, in its acquisition by Illinois Tool Works Inc. (2008)

Securities transaction for BlueView Technologies

Series A senior preferred stock and Series B preferred stock angel financings for ultrasound device developer. (2008)

Corporate finance for Confirma, Inc.

Represented a medical device software developer in a Series C Preferred Stock financing by Telegraph Hill Partners; a venture loan from Silicon Valley Bank and Oxford Finance Corporation; convertible debt financing from Versant Ventures, Prism Ventures, Fluke Ventures, and Northwest Venture Partners; and a strategic alliance with GE Healthcare. (2007)

Sale of business for Healia

Represented medical device software developer in its sale to Meredith Corp. (2007)

Sale of business for InstruMed

Sale of medical device equipment manufacturer to Stryker Corp. (2007)

Securities transaction for Julep Nail Parlor Company

Series A preferred stock angel financing for retail service company. (2007)

Securities transaction for Previser

Represented medical device software company in a Series A preferred stock financing from Ignition Partners. (2007)

Securities transaction for Verdiem Corporation

Series D preferred stock financing of energy efficiency software developer by Catamount Ventures. (2006)

Strategic license and merger for UST, Inc.

Represented UST, Inc., a medical device developer, in its strategic development and license agreement with Atricure, Inc., and merger into High Grade Technology, Ltd. (2006)

Acquisition of business for MDS PharmaServices

Represented MDS in its acquisition of Skeletech, a therapeutically focused contract research organization. (2005) Read more

Sale of business for Zetta Systems

Sale of software developer to Overland Storage. (2005)

Securities transaction for UBMatrix, Inc., an XBRL platform developer

Represented XBRL platform developer in Series A senior preferred stock financing from Draper Fisher Jurvetson. (2005)

Licensing agreements for Ultreo

Negotiated a technology license from the University of Washington for a consumer health care products company. (2004)

Sale of business for 4thPass, Inc.

Represented 4thPass, Inc., a wireless applications developer, in its acquisition by Motorola, Inc. (2002)

Securities transaction for Needham & Company

Underwriter's counsel in public offering of Cray, Inc. (2002)

Professional & Community Activities

  • Board of Advisors, Science & Engineering Business Association, University of Washington 
  • Member, Technology Advisory Council for U.S. Rep. Adam Smith (D-Wash.)
  • Prior Board Member, Northwest Entrepreneur Network
  • Prior Board Member, Washington Biotechnology & Biomedical Association
  • Prior General Counsel, Tacoma Angel Network
  • Prior Chair, MIT Enterprise Forum of the Northwest
  • Prior Board Member, Forum for Women Entrepreneurs
  • Federal Securities Regulation Committee; Venture Capital Committee – Business Section, American Bar Association
  • Trustee, Holy Names Academy
  • Co-Chairman, Friends of Seattle Mombasa Schools 

Professional Recognition

  • Named as one of "America’s Leading Business Lawyers" in Corporate Commercial (Washington) by Chambers USA, 2004-2014
  • Named as one of the "Best Lawyers in America" in Corporate Law and in M&A Law by Best Lawyers, 2007-2008, 2010-present
  • Selected to "Washington Super Lawyers," Thomson Reuters, 2003-2004, 2011-2014
DWT recognized by chambers USA, read release